Director · Immuneering Corp · Immuneering Corp — Stock Option
Side
A
Value
—
Shares
33.4K
Price
—
Executed
Jun 11, 2026
Disclosed
Jun 11, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Jun 11 executedJun 11, 2026 disclosed
IMRX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Schall Thomas J. filed this Form 4 reporting a grant or award of IMRX on Jun 11, 2026. It became public on Jun 11, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Schall Thomas J.cik:0001423084
Issuer
Immuneering Corpcik:0001790340
Revision history · 0
No field has changed since this record was first ingested.
